Instant Impact’s Post

The biopharma industry is evolving rapidly with the emergence of new technologies and methodologies 🔬 MarketsandMarkets™ projects that the global biotech market, driven by groundbreaking advancements and innovative approaches, will reach $465.9 billion in 2024. In our latest article, Roman Bevz, our Head of Business Consulting and Advisory Practice, explores these advancements shaping the sector 🔍 Discover the latest trends in #biopharma, including AI-driven drug discovery, personalized medicine, and other transformative technologies. 🖇️ https://lnkd.in/dQcSqNyE  #Avenga  #AvengaInsights #Biotech #PersonalizedMedicine #TechTrends  

Faster drug discovery & personalized medicine, enhanced development processes, improved operational efficiencies, and real-world industry use cases. Watch this recorded webinar on the #GenAI revolution in pharma, biotech, and CROs! https://dell.to/3LUo5pg #TransformHIT

Our recent webinar Enhancing Biopharma's Path-to-Market is now available to watch on demand. Hear from Jacqueline Barendregt, COO of IDEA Pharma | From R&D to RxD and our CEO Aiden Flynn who discuss the concept of design-thinking path-to-market strategies, which are increasingly being recognised as pivotal in the biopharma sector. Key takeaways include: 💡 Design-Thinking Path-to-Market Strategies: Learn how to integrate these strategies with advanced analytics and simulation for better decision-making. 📊 Case Studies: Discover how innovative solutions have driven clinical milestones, including an Alzheimer's trial. 🛠️ KerusCloud Demonstration: See how this platform can streamline trials, reduce costs, and improve success rates. Watch on demand below: https://lnkd.in/gUdJVAMZ #Biopharma #ClinicalSuccess #MarketStrategy #InnovativeTherapies #Webinar #ResearchandDevelopment #biotech #Pharma

Will you be at the #DrugDeliverySummit? 💊 DM Dan Dobry or David Vodak if you'd like to set up some time to meet. 💡 Let's talk about the next innovation in drug development. #PharmaCDMO #ContractManufacturing #DrugDevelopment #CDMOsolutions #InnovativeTherapeutics #AIinPharma Bend Bioscience + CoreRx, Inc.

This is really interesting! Nimbus Therapeutics has made waves with this setup, which started with Bruce Booth from Atlas Venture. It’s impressive how this model has led to deals worth over $7.1B, returned $4.1B to investors, and pushed three programs into clinical trials. It shows that while the business model is important, solid science and data are key. #biotech, #pharma, #businessmodel

Industry professionals can learn a lot from the top ten clinical trial failures of 2023. These trials spanned various therapeutic areas, demonstrating the challenges and uncertainties inherent in drug development. The insights from these failures provide an opportunity for fostering discussions around best practices, innovative approaches, and risk management in clinical research. Check out the full article to stay updated with the latest in biotech industry developments. #clinicaltrials #biotech #drugdevelopment

With #Oligos taking up a larger presence in drug development and therapeutic manufacturing - we love working in tandem with those at the forefront of development! 🧑🔬 Have a watch of our first video below - learn why industry experts love working with Shimadzu UK Limited and if you have any questions or requirements, let me know! #analyticalinstruments #pharma #research

According to Deloitte, developing a new drug costs about $2.3 billion. This hefty price tag is often accompanied by high hopes, but not all clinical trials are successful. Fierce Biotech has compiled a list of the top 10 clinical trial flops in 2023. Check out the article for an insightful read on the challenges of drug development. https://lnkd.in/eRjy65P6

Understand how greater #supplychain resilience may increase capacity, and accelerate drug discovery and therapeutics. Download this report on the outlook for life science #lifesciences supply chains! 👇

📢 Exciting News! AmpleLogic is proud to be a Silver Sponsor at Federation of Asian Biotech Associations (FABA)! On August 7th at 11 AM, our very own Mr. Manne Venkanna Chowdary will take the virtual stage to discuss "Harnessing Digital Technologies for Enhanced Drug Manufacturing in Pharma." We're thrilled to be part of this insightful session! #AmpleLogic #FABA #DigitalTransformation #PharmaInnovation #IndustryLeadership